Rudolf Jaenisch is a founding member of the Whitehead Institute for Biomedical Research and a Professor of Biology at the Massachusetts Institute of Technology. He earned his M.D. from the University of Munich, where he specializes in transgenic science, which genetically modifies animals such as mice to study human diseases such as cancer. He completed his postdoctoral work at the Max Planck Institute, where he studied bacteriophages.
His laboratory has made breakthroughs that have improved therapies for sickle-cell anemia and Parkinson’s Disease. Jaenisch has been a vocal advocate for using transgenic methods to alter human cells, but he is opposed to human reproductive cloning.
Jaenisch’s work has received numerous awards, including the very first Genetics Prize of the Gruber Foundation, the Robert Koch Prize, the Max Delbruck Medal, Vilcek Prize in Biomedical Science, the Ernst Schering Prize, a National Medal of Science, the Wolf Prize in Medicine, the Otto Warburg Medal, and in 2015, the March of Dimes Prize in Developmental Biology. He is currently researching epigenetic regulation of gene expression, advancing our understanding of embryonic stem cells, and induced pluripotent stem cells.
He has held positions at Princeton University, Fox Chase Institute for Cancer Research, and the Salk Institute. He also contributed to the United Nation’s science conference on human cloning.
Featured in Top Influential Biologists Today
Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer and neurological diseases.Source: Wikipedia
Research university in Cambridge, Massachusetts, United Statesview profile
German university in Munich, Bavariaview profile